Imidazo[1,2-a]pyrazine-3-carbaldehyde

Catalog No. :
ACIQPU957
CAS No. :
106012-58-2
Molecular Formula :
C7H5N3O
Molecular Weight :
147.14

IUPAC Name:imidazo[1,2-a]pyrazine-3-carbaldehyde

Imidazo[1,2-a]pyrazine-3-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$79.00Login to see priceIn stockInquiry
1g95%$216.00Login to see priceIn stockInquiry
5g95%$929.00Login to see priceInquiryInquiry
25g95%$3180.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameImidazo[1,2-a]pyrazine-3-carbaldehyde
IUPAC Nameimidazo[1,2-a]pyrazine-3-carbaldehyde
MDL No.MFCD09027562
Molecular FormulaC7H5N3O
Molecular Weight147.14
SMILESO=CC1=CN=C2C=NC=CN12
InChI KeyFTYAMGYSJHEZQA-UHFFFAOYSA-N
SynonymIMIDAZO[1,2-A]PYRAZINE-3-CARBALDEHYDE;Imidazo[1,2-a]pyrazine-3-carboxaldehyde (9CI);Imidazo[1,2-a]pyrazine-3-carboxaldehyde;3-imidazo[1,2-a]pyrazinecarboxaldehyde;IMIDAZO[1,2-A]PYRAZINE-3-CARBALDEHYDE ISO 9001:2015 REACH;Imidazo[1,2-a]pyrazine-3-carboxaldehyde - [AC77561]
CAS No.106012-58-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACIQPU957 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUITO835 route compound structure diagram
    ACUITO835274-79-3 In Stock
  4. Then
  5. ACIQPU957 route product structure diagram
    ACIQPU957106012-58-2 In Stock
Inquiry

2. ACIQPU957 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCQSZ257 route compound structure diagram
    ACCQSZ25757948-41-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIQPU957 route product structure diagram
    ACIQPU957106012-58-2 In Stock
Inquiry

Comments (0)